Gene therapy for the hematopoietic system, ie for diseases affecting lymphocytes, require that the genetically modified hematopoietic precursor cells retain the potential to generate mature and functional progeny, eg T cells. 1 Moreover, proliferation is essential for nonlentiviral retroviral gene transfer. 2, 3 Cell cycle induction may be necessary for lentiviral gene transfer. 4, 5 Finally, expansion of the cell number after gene transfer will sometimes be necessary when cord blood (CB) is used as a source of transplantable hematopoietic precursor cells (HPC). 6 Numerous gene-marking studies have indicated that ex vivo transduced human HPC have a reduced repopulating potential. 1, [7] [8] [9] [10] [11] [12] [13] The true stem cell, a HPC population that is both self-renewing and totipotent, seems to be rare in the cytokine responsive HPC that are targeted by retroviral gene transfer. However, several groups have attempted to cure patients with retrovirally transduced HPC, including patients suffering from disease affecting T cells. 1, 10, 11, 14 In both juveniles and adults, T cells are generated in the thymus. [15] [16] [17] For successful gene therapy, 
CD38
− HPC, in a magnitude that is determined by the cytokine cocktail used during culture. Gene Therapy (2000) 7, 830-836.
genetically modified HPC should retain thymus-repopulating potential.
We previously described a fetal thymus organ culture (FTOC) model that allowed us to test thymus-repopulating potential of retrovirally transduced HPC in vitro. 3 This model was recently used to demonstrate thymusrepopulating potential of cultured CB HPC, and validated in vivo by SCID-hu experiments. 18 We used stem cell factor (SCF), thrombopoietin (TPO), flt3/flk-2 ligand (FL), interleukin(IL)-3 and IL-6 to expand the number of CB cells over 1 or more weeks of culture. Here, we sought to compare the influence of HPC maturity and cytokine cocktails on proliferation and T cell generation from retrovirally transduced CB HPC. Highly purified CD34 
Results

Transduction efficiency of CD34
+
Lin
− cord blood cells cultured in stroma-free liquid culture We have previously analyzed T cell generation from cultured CD34 + CB cells. In these experiments, we compared the cytokine cocktails TPO + FL ± SCF and IL-3 + SCF ± IL-6. 18 We now first studied the effect of the different cocktails on gene transfer efficiency to purified CD34 +
CD38
+ and CD34 + CD38 − CB cells. These purified populations were transduced with MFG-EGFP retrovirus, that encodes green fluorescent protein (GFP). CD34
+
CD38
+ cells were more readily transduced than CD34 +
− cells, irrespective of the cytokine mix used (Figure 1) . Of the cytokine combinations tested, TPO + FL was clearly inferior to the others: on average, 29% of the cells in CD34 + CD38 + cultures and 10% of the cells in CD34 +
− cultures were GFP + . Addition of SCF to this mix increased gene transfer efficiency to an average of 58% and 32%, respectively. Gene transfer efficiencies measured in IL-3 + SCF ± IL-6 supplemented cultures were similar to those in TPO + FL + SCF supplemented cultures. 
Expansion of gene-marked human CD34
CD38
+ CB cell cultures, used to initiate the FTOC. Consequently, the average ratio between both GFP + fractions is less than 1 ( Table 1) . Except in the case of TPO + FL supplemented cultures, FTOC initiated with CD34 + CD38 + CB cells cultured for 17 days showed an even more reduced fraction of GFP + thymocytes generated. However, FTOC initiated with day 3 CD34 + CD38 − CB cell cultures contained a considerably higher fraction of GFP + thymocytes compared with the fraction of GFP + HPC that initiated the FTOC. The highest ratio was found in cultures using HPC transduced and cultured in TPO + FL supplemented medium. Therefore, the relatively few GFP + HPC from these cultures seem to generate about four times more thymocytes in FTOC than GFP − HPC from the same culture.
In the other cytokine cocktails tested, the ratio was about 2. Again, on average a smaller fraction of thymocytes expressing the marker 
Lin
− CB cells, the number of thymus-repopulating cells can be expanded. 18 To determine the fate of gene-marked HPC during extensive culture, we performed a series of FTOC-limiting dilution experiments starting from transduced CD34 +
CD38
− cells. Again HPC were not selected for GFP expression before initiation of FTOC. As shown in Table 2 , in FTOC initiated with the progeny 
− CB cells (initial transduction percentage see Figure 1 ), that were cultured in medium supplemented with the cytokine mix and for the number of days as indicated. Between brackets: raw data used to calculate fraction (absolute number over total number of lobes analyzed). Data shown are pooled results of experiments with two CB donors, * and°indicate significant difference between day 10 or day 17 and day 3 (*:P Ͻ 0.05;°:P Ͻ 0.01, binomial test Several clinical trials with genetically engineered HPC have been performed. [7] [8] [9] [10] [11] [12] [13] The general consensus that emanated from these studies was the poor repopulating potential of gene-marked cells. In the mature progeny of transplanted HPC, the gene-marked fraction was low compared with that in the infused donor HPC, and progressively declined over the first months post-transplant in most studies. However, several months after transplant, gene-marked HPC were present in the bone marrow. 1, 25 Also in the few trials where generation of T cells from transduced HPC was an end-point, the frequency of gene-marked peripheral blood T cells was disappointingly low. 10, 11 This could point to a selective disadvantage of transduced cells to differentiate, caused by toxicity of, or by host immune response to, the transgene Gene Therapy product.
1 From our data we suggest that gene transfer per se does not induce an intrinsic differentiation defect. Moreover, we could generate transduced thymocytes in vivo after injection of transduced CD34 +
+ CB cells, cultured for 3 weeks, in the human thymus of a SCIDhu mouse (Ref. 18 and data not shown). This observation suggests that in vivo no barrier exists that blocks T cell generation from the transduced and cultured HPC. Rather, the relative inability to generate mature transgenic progeny observed in the clinical trials might result from the inability of gene-marked HPC to home to the appropriate niche, or to retain the capacity to generate mature progeny over extended periods. Possibly, HPC with this capacity are not recruited into cell cycle during cytokine supplemented culture in the transduction protocol. Recently, encouraging data were published on NOD-SCID repopulation by lentivirally transduced HPC. 4 18 These results indicated an overall increase in the number of thymusrepopulating cells most prominent in TPO + FL + SCF and to a lesser extent in IL-3 + SCF ± IL-6 supplemented cultures, while TPO + FL supplemented cultures were clearly inferior in this respect. Here, we observed that in TPO + FL supplemented CD34 +
− cultures especially the GFP + HPC retain thymus repopulating potential (Table 1) . However, again no expansion of these cells was observed in the limiting dilution experiments (Table 2 ). Our interpretation is that proliferation of CD34 + cells, either transduced or not, is clearly inferior in TPO + FL supplemented cultures, compared with the other combinations tested (Figure 2) . However, on a cell basis, CD38 − cells transduced in TPO + FL have compared with nontransduced cells, the highest growth advantage in FTOC as that observed with the other cytokine combinations tested. In other words, those CD38
− cells recruited into cell cycle and therefore transduced in the TPO + FL cytokine mix seem to be much more efficient in generating thymocytes than nontransduced cells, while in the other cytokine mixes this difference was less pronounced. Expansion of the number of GFP + thymus-repopulating cells was most prominent in cultures of CD34 +
− CB cells supplemented with TPO + FL + SCF. Addition of SCF was essential, since of the combinations tested, only TPO + FL supplemented cultures failed to show expansion of gene-marked thymus-repopulating cells.
Recent evidence supports the notion that the thymus remains functional and continues to generate naive T cells in adults. [15] [16] [17] However, analysis of transplantations with transduced cells suggests that long-term repopulation by retrovirally transduced cells is inadequate. Lentiviral gene transfer might alleviate this constrain. Our observation that gene-marked, expanded HPC retain thymus-repopulating capacity has encouraging implications for gene therapy of diseases affecting T cells, such as ADA deficiency, AIDS and X-linked SCID. Biotinylated antibodies were revealed by streptavidin-TC (SA-TC, Caltag Laboratories), SA-PE or SA-APC (BDIS). mAbs from ATCC were FITC or BIO conjugated in our laboratory by standard methods. Flow cytometry and cell sorting was done as described previously. 3, 18 Briefly, cells were suspended in PBS containing 1% (w/v) BSA and 0.1% (w/v) NaN 3 . In all cases where human cells were stained in the presence of mouse cells, the mixture of cells was pre-incubated for 15 min with saturating amounts of anti-Fc␥RII/III mAb to avoid nonspecific binding of mAbs by the murine cells. Subsequently, the cells were stained with a panel of mAbs, as indicated. If present, murine and dead cells were gated out by mouse CD45 Cychrome and propidium iodide, respectively. Negative controls included isotype mAbs conjugated with the corresponding fluorochrome. The cells were analyzed on a FACScan or FACSCalibur flow cytometer or sorted on a FACSVantage cell sorter (BDIS). Forward light scattering, orthogonal scattering and three or four fluorescence signals were stored and analyzed using the CellQuest software (BDIS).
Purification of CD34
+ cord blood cells Umbilical cord blood was obtained from full-term, healthy newborns and used within 24 h after collection for isolation of mononuclear cells as described before. 3 Briefly, the cryopreserved mononuclear cell fraction, depleted for glycophorin-A, CD19 and CD7, was stained with CD1, CD3, CD4, CD8, CD34 and CD38. Cells that were CD34 PE 
Lin
− cells. Sorted cells were checked for purity, which was always at least 99%.
Cytokines
All cytokines were used at a fixed concentration during culture: 100 ng/ml recombinant human SCF (R&D Systems Europe, Abingdon, UK), 100 ng/ml recombinant human FL (R&D Systems Europe), 20 ng/ml TPO (R& D Systems Europe), 10 ng/ml recombinant human IL-3 (Innogenetics, Antwerp, Belgium), 100 U/ml recombinant human IL-6 (produced in yeast, kindly provided by Dr W Fiers, University of Ghent, Belgium, specific activity 280 U/ng).
Cell culture
All cultures were done at 37°C in a humidified atmosphere containing 7.0% (v/v) CO 2 in air. The cells were cultured in Iscove's modified Dulbecco's medium (IMDM) as described before. 18 Cytokine supplemented medium was refreshed at least twice a week. For FTOC-limiting dilution experiments, cells harvested for FTOC at each point were distributed over several instead of one fetal thymic lobes, as described before. 18 Briefly, one lobe was cultured with 75% of the cells, three lobes with 5% of the cells each and six to nine lobes with 1% of the cells each. FTOC-limiting dilution was done only with CD34 +
CD38
− cells, and the number of cells distributed over the lobes at each harvest corresponded to 1000 sorted cells. Therefore, lobes receiving 1% of the harvested cells received the progeny equivalent to that of 10 CD34 +
− cells.
Retroviral gene transfer
For transduction, half of the volume of the culture medium was replaced with viral supernatant, supplemented with cytokines (to keep final cytokine concentration unchanged) and cells were seeded in 96-well flat bottom non-tissue culture-treated plates (Falcon), coated with RetroNectin (Takara Biomedicals, Otsu Shiga, Japan) as instructed by the supplier. The retrovirus used encoded the marker gene green fluorescent protein (EGFP, Clontech, Palo Alto, CA, USA), constructed and produced as described previously. 3 Briefly, an NcoIBamHI fragment containing GFP was inserted between the unique corresponding restriction sites of the MFG retroviral vector. Consequently, GFP was the only protein encoded by the retrovirus. A stable transfected Phoenix-A retroviral packaging line was established. 3 Aliquots of pooled retroviral supernatant were stored at −70°C. The batch used in this report was shown to be free of replication competent retrovirus and contained after thawing 1 × 10 6 transforming units/ml (titrated on Jurkat T-cells (ATCC), data not shown).
Mice
Fetal day 15 thymic lobes were isolated as described before from C.B.-17 scid/scid (SCID) or NOD-LtSz-scid/scid (NOD-SCID) mice, bred in our specific pathogen-free breeding facility. 3 Human tissue was obtained following the guidelines of the Medical Ethical Commission of the University Hospital of Ghent. Animals were treated according to the guidelines of the Laboratory Animal Ethical Commission of the University Hospital of Ghent.
Fetal thymic organ culture (FTOC)
Hanging drops were prepared in Terasaki plates by adding per well 25 l complete IMDM containing the progeny or a fraction thereof of CD34
+
Lin
− cells after washing in complete cytokine-free medium. To each well, one fetal thymic lobe was added, the plates were inverted to form hanging drops and incubated for 72 h. After this incubation, at day 0 of FTOC, the lobes were removed, washed in complete medium, and cultured for 30 days as described before. 3 For limiting dilution experiments, harvested cells were co-incubated with NOD-SCID lobes and irradiated CD34 + cells as described before. 29 At the end of the culture, lobes were mechanically disrupted with a small tissue grinder to obtain a single cell suspension for evaluation with flow cytometry.
Statistical analysis
Results from FTOC-limiting dilution experiments were analyzed with the binomial test; gene-marking ratios in FTOC were analyzed with the randomization test for two independent samples.
